Hikma Participates in 2019 World Economic Forum Annual Meeting in Davos, Switzerland

Amman, Jordan, 27 January 2019 - Hikma Pharmaceuticals PLC (Hikma, Group) (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY) (rated Ba1 Moody’s / BB+ S&P, both stable), the multinational generic pharmaceutical company, is pleased to have participated in the 2019 World Economic Forum (WEF) Annual Meeting held in Davos, Switzerland, for the eleventh consecutive year.

Press Release Responsibility 28 January 2019

Under the theme of “Globalization 4.0: Shaping a Global Architecture in the Age of the Fourth Industrial Revolution”, the Annual Meeting took place between 22 - 25 January and comprised a series of panel discussions on related topics, such as artificial intelligence, the future of health and healthcare, education, gender and work, climate change and humanitarian crises, among others. Participants included scientists, CEOs, academics, politicians and artists.


As a WEF Health Industry Partner, Hikma connected with an extensive network of prominent health industry leaders, including other international pharmaceutical companies, major health centres and hospitals, as well as top research and development centres and universities, to advance the state of worldwide health.


Moreover, as a founding member of the Partnering Against Corruption Initiative, (PACI), Hikma took part in the PACI session, which tackled pressing regional matters on industry anti-corruption and transparency issues. The PACI is the foremost CEO-led anti-corruption initiative, working with international organisations, academics and government institutions to rebuild and foster trust in business and institutions.


Representing Hikma at the Annual Meeting, Hikma Executive Vice Chairman and President of MENA, Mazen Darwazah, commented, “As an organization dedicated to helping put better health within reach, we have always believed that business has a key role in advancing and protecting vulnerable communities, building more inclusive societies and ensuring equal progress benefits. To this end, we are proud to participate once again in the World Economic Forum Annual Meeting and leverage this progressive platform with thought leaders who share our vision of a healthier world.”

Important notice for users

You are about to access Hikma historic archive material. Any reference in these archives to Hikma products or their uses may not reflect current medical knowledge and should not be used as a source of information on the present product label, efficacy data, or safety data. Please refer to your approved national product label (SmPC) for current product information.

I have read this warning and will not be using any of the contained product information for clinical purposes.